Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial (Q34033475)

30 July 2017

title

Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial (English)

1 reference

30 July 2017

Suzanne Kamel-Reid

0 references

Stuart Watt

0 references

Philippe L Bedard

0 references

John D McPherson

0 references

Lincoln D Stein

1 reference

30 July 2017

Ben Tran

1 reference

30 July 2017

Andrew M K Brown

1 reference

30 July 2017

Eric Winquist

1 reference

30 July 2017

Glenwood D Goss

1 reference

30 July 2017

Sebastien J Hotte

1 reference

30 July 2017

Stephen A Welch

1 reference

30 July 2017

Hal W Hirte

1 reference

30 July 2017

Tong Zhang

1 reference

30 July 2017

Vincent Ferretti

1 reference

30 July 2017

Wei Jiao

1 reference

30 July 2017

Karen Ng

1 reference

30 July 2017

Sangeet Ghai

1 reference

30 July 2017

Patricia Shaw

1 reference

30 July 2017

Teresa Petrocelli

1 reference

30 July 2017

Thomas J Hudson

1 reference

30 July 2017

Benjamin G Neel

1 reference

30 July 2017

Nicole Onetto

1 reference

30 July 2017

Lillian L Siu

1 reference

30 July 2017

Janet E Dancey

1 reference

30 July 2017

language of work or name

English

0 references

publication date

11 October 2012

1 reference

International Journal of Cancer

30 July 2017

published in

1 reference

30 July 2017

volume

132

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

1547-1555

1 reference

International network of cancer genome projects

30 July 2017

cites work

1 reference

Detection of KRAS and BRAF mutations in colorectal carcinoma roles for high-sensitivity locked nucleic acid-PCR sequencing and broad-spectrum mass spectrometry genotyping

21 January 2018

1 reference

Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry

21 January 2018

1 reference

The BATTLE trial: personalizing therapy for lung cancer

21 January 2018

1 reference

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials

21 January 2018

1 reference

Profiling critical cancer gene mutations in clinical tumor samples

21 January 2018

1 reference

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

21 January 2018

1 reference

Next-generation sequencing: ready for the clinics?

21 January 2018

1 reference

Advances in Whole Genome Sequencing Technology

21 January 2018

1 reference

Personalized oncology through integrative high-throughput sequencing: a pilot study

21 January 2018

1 reference

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

The genetic basis for cancer treatment decisions

21 January 2018

1 reference

Sequencing technologies - the next generation

21 January 2018

1 reference

Personalized medicine in oncology: the future is now.

21 January 2018

1 reference

Cancer genomics: technology, discovery, and translation

21 January 2018

1 reference

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

21 January 2018

1 reference

In silico identification of significant detrimental missense mutations of EGFR and their effect with 4-anilinoquinazoline-based drugs.

21 January 2018

1 reference

Genome remodelling in a basal-like breast cancer metastasis and xenograft

21 January 2018

1 reference

Tumour evolution inferred by single-cell sequencing

21 January 2018

1 reference

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

21 January 2018

1 reference

PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.

21 January 2018

1 reference

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.

21 January 2018

1 reference

Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer.

21 January 2018

1 reference

PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27817

1 reference

30 July 2017

1 reference